CJC-1295 w/DAC
CJC-1295 with DAC is a modified GHRH analog with prolonged half-life through albumin binding, enabling sustained somatotroph axis activation in experimental models.
Wholesale Pricing
Available Doses & Tiered Pricing
CJC-1295 w/DAC 5mg
Save 30%- 50 vials$50.00 / vial
- 100 vials$45.00 / vial
- 250 vials$40.00 / vial
- 500 vials★ Best Value$35.00 / vial
Overview
CJC-1295 with DAC is a modified GHRH analog with prolonged half-life through albumin binding, enabling sustained somatotroph axis activation in experimental models.
History
Developed by ConjuChem in the early 2000s; reached phase II programs.
Key Areas of Research
- Sustained somatotroph axis activation
- IGF-1 dynamics
- Downstream endocrine cascades
References
- Teichman S.L. et al. (2006). JCEM 91(3):799–805.
- Lapierre S.S. et al. (2006). Am J Physiol Endocrinol Metab 291(2):E282–E287.
Research Use Only
All products are intended solely for laboratory research purposes and are not for human or animal consumption. Must be handled by qualified professionals.
Related Compounds
Growth Hormone
Tesamorelin
Tesamorelin is a synthetic GHRH analog studied for somatotroph axis modulation and downstream signaling cascades in laboratory models.
View details →Growth Hormone
Sermorelin
Sermorelin is a synthetic peptide analog of GHRH (1-29) studied for modulation of somatotroph axis signaling and associated downstream cascades.
View details →Growth Hormone
Ipamorelin
Ipamorelin is a synthetic pentapeptide and selective secretagogue-type agonist with minimal off-target pathway interference, used to study endocrine signaling and somatotroph axis modulation.
View details →